ArticleMolecular cancer therapeutics2019

AKR1C3 Promotes AR-V7 Protein Stabilization and Confers Resistance to AR-Targeted Therapies in Advanced Prostate Cancer.

Chengfei Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.